Literature DB >> 19132246

Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma.

Anton M H P van den Besselaar1, Evelina Witteveen, Felix J M van der Meer.   

Abstract

The CoaguChek S system is designed for use in patient self-testing. In this system a whole blood sample without sodium citrate is applied to a test strip containing thromboplastin and iron oxide particles. The detection principle is based on fibrin formation which inhibits and finally stops the movement of the iron oxide particles. In the classic prothrombin time (PT) test, citrate plasma is mixed with thromboplastin and an excess of calcium ions. In the monitoring of vitamin K-antagonist (VKA) treatment, all results are expressed on a common scale, i.e. international normalised ratio (INR). In patients on long-term VKA treatment, INRs were determined by the CoaguChek S system and reference methods for the classic PT. Four different CoaguChek S strip lots were evaluated. The difference in INR between the reference PT and the CoaguChek S system was negatively correlated to the haematocrit of the patients. We conclude that INR differences between CoaguChek S and plasma PT may be explained in part by the haematocrit. The magnitude of the effect of haematocrit, within the reference interval of 0.37 - 0.51, on the INR difference was not greater than approximately 10% for the combined data of the four strip lots. A bias of less than 10% seems to be acceptable clinically.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19132246     DOI: 10.1160/th08-04-0257

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Micro-mechanical blood clot testing using smartphones.

Authors:  Justin Chan; Kelly Michaelsen; Joanne K Estergreen; Daniel E Sabath; Shyamnath Gollakota
Journal:  Nat Commun       Date:  2022-02-11       Impact factor: 14.919

2.  International normalized ratio testing with point-of-care coagulometer in healthy term neonates.

Authors:  Shigeo Iijima; Toru Baba; Daizo Ueno; Akira Ohishi
Journal:  BMC Pediatr       Date:  2014-07-09       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.